European Journal of Integrative Medicine
Volume 1, Issue 2 , Pages 73-79 , July 2009

Concomitant administration of petroleum ether extract of the stem bark of Pongamia pinnata (L.) Pierre with synthetic oral hypoglycaemic drugs in alloxan-induced diabetic mice

Received 25 March 2009 ,Revised 3 May 2009 ,Accepted 6 May 2009.

References 

  1. Krishnamurthi A. The wealth of India-raw materials, vol-VIII: Ph-Re. New Delhi, India: publication and information directorate. Council of Scientific and Industrial Research. 1998;206–211
  2. Khare CP. Encyclopedia of Indian medicinal plants. New York: Springer; 2004;p. 378–9
  3. Aiman R. Recent research on indigenous antidiabetic medicinal plants-an overall assessment. Ind J Physiol Pharmacol. 1970;14:65–76
  4. Koysomboon S, Altena IV, Kato S, Chantrapromma . Antimicrobacterial flavonoids from Derris indica. Phytochemistry. 2006;67:1034–1040
  5. Punitha R, Vasudevan K, Manoharan S. Effect of Pongamia pinnata flowers on blood glucose and oxidative stress in alloxan induced diabetic rats. Indian J Pharmacol. 2006;38:62–63
  6. Punitha R, Manoharan S. Antihyperglycemic and antilipidperoxidative effects of Pongamia pinnata (Linn.) flowers in alloxan induced diabetic rats. J Ethnopharmacol. 2006;105:39–46
  7. Tamrakar AK, Yadav PP, Tiwari P, Maurya R, Srivastava AK. Identification of pongamol and karanjin as lead compounds with antihyperglycemic activity from Pongamia pinnata fruits. J Ethnopharmacol. 2008;118:435–439
  8. Ju JB, Kim JS, Choi WC, Lee HK, Oh TK, Kim SC. Comparison between ethanolic and aqueous extracts from Chinese juniper berries for hypoglycaemic and hypolipidemic effects in alloxan induced diabetic rats. J Ethnopharmacol. 2008;115:110–115
  9. Singh M, Varshneya C, Telang RS, Srivastava AK. Alteration of pharmacokinetics of oxytetracycline following oral administration of Piper longum in hens. J Vet Sci. 2005;6:197–200
  10. Lin YC, Bioteau AB, Ferrari LR, Berde CB. The use of herbs and complementary and alternative medicine in pediatric preoperative patients. J Clin Anesth. 2004;16:4–6
  11. Izzo AA. Herb–drug interactions: an overview of the clinical evidence. Fundam Clin Pharmacol. 2005;19:1–16
  12. Badole SL, Bodhankar SL. Investigation of antihyperglycaemic activity of alcoholic extract of stem bark of Pongamia pinnata on serum glucose level in diabetic mice. Pharma Biol. 2008;46:900–905
  13. Badole SL, Bodhankar SL. Investigation of antihyperglycaemic activity of aqueous and petroleum ether extract of stem bark of Pongamia pinnata on serum glucose level in diabetic mice. J Ethnopharmacol. 2009;
  14. Davis SN, Granner DK. Insulin, oral hypoglycemic agents and the pharmacology of endocrine pancreas. In:  Gilman AG,  Goodman LS,  Hardman JG,  Limbard LE editor. The pharmacological basis of therapeutics. 10th ed.. New York: McGraw-Hill; 2001;p. 1701–1703
  15. Gumieniczek A. Effect of the new thiazolidinedione-pioglitazone on the development of oxidative stress in liver and kidney of diabetic rabbits. Life Sci. 2003;74:553–562
  16. Owens DR. Repaglinide—prandial glucose regulator: a new class of oral antidiabetic drugs. Diab Med. 1998;15:S28–S36
  17. Badole SL, Bodhankar SL. Antihyperglycaemic activity of cycloart-23-ene-3β, 25-diol isolated from stem bark of Pongamia pinnata in alloxan induced diabetic mice. Res J Phytochem., doi:10.3923/rjphyto.2009.18.24.

PII: S1876-3820(09)00025-0

doi: 10.1016/j.eujim.2009.05.003

European Journal of Integrative Medicine
Volume 1, Issue 2 , Pages 73-79 , July 2009